Literature DB >> 6296391

Genetics of plasma paroxonase activity.

L Iselius, D A Evans, J R Playfer.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6296391      PMCID: PMC1048954          DOI: 10.1136/jmg.19.6.424

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  8 in total

1.  Genetic polymorphism and interethnic variability of plasma paroxonase activity.

Authors:  J R Playfer; L C Eze; M F Bullen; D A Evans
Journal:  J Med Genet       Date:  1976-10       Impact factor: 6.318

2.  Skewness in commingled distributions.

Authors:  C J Maclean; N E Morton; R C Elston; S Yee
Journal:  Biometrics       Date:  1976-09       Impact factor: 2.571

3.  Analysis of family resemblance. 3. Complex segregation of quantitative traits.

Authors:  N E Morton; C J MacLean
Journal:  Am J Hum Genet       Date:  1974-07       Impact factor: 11.025

4.  [Genetically determined polymorphism of human serum paraoxonase (EC 3.1.1.2)].

Authors:  H H Lindorf; M Petenyi; M Flügel; T Fischer; T Hiller
Journal:  Humangenetik       Date:  1973

5.  Analysis of family resemblance. IV. Operational characteristics of segregation analysis.

Authors:  C J MacLean; N E Morton; R Lew
Journal:  Am J Hum Genet       Date:  1975-05       Impact factor: 11.025

6.  Genetics of paraoxonase.

Authors:  H Eiberg; J Mohr
Journal:  Ann Hum Genet       Date:  1981-10       Impact factor: 1.670

7.  Complex segregation analysis with pointers.

Authors:  J M Lalouel; N E Morton
Journal:  Hum Hered       Date:  1981       Impact factor: 0.444

8.  On the genetics of the human serum paraoxonase (EC 3.1.1.2).

Authors:  M Geldmacher-v Mallinckrodt; G Hommel; J Dumbach
Journal:  Hum Genet       Date:  1979-09       Impact factor: 4.132

  8 in total
  1 in total

1.  Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration.

Authors:  Gayle J T Pauer; Gwen M Sturgill; Neal S Peachey; Stephanie A Hagstrom
Journal:  Am J Ophthalmol       Date:  2009-12-30       Impact factor: 5.258

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.